[1]
|
Zhou, M., et al. (2019) Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. Lancet, 394, 1145-1158.
https://doi.org/10.1016/S0140-6736(19)30427-1
|
[2]
|
Patel, M.R., Peterson, E.D., Dai, D., Brennan, J.M., Redberg, R.F., Anderson, H.V., et al. (2010) Low Diagnostic Yield of Elective Coronary Angiography. The New England Journal of Medicine, 362, 886-895.
https://doi.org/10.1056/NEJMoa0907272
|
[3]
|
Kunadian, V., Chieffo, A., Camici, P.G., Berry, C., Escaned, J., Maas, A., et al. (2020) An EAPCI Expert Consensus Document on Ischaemia with Non-Obstructivecoronary Arteries in Collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology and Microcirculation Endorsed by Coronary Vasomotor Disorders International Study Group. European Heart Journal, 41, 3504-3520. https://doi.org/10.1093/eurheartj/ehaa503
|
[4]
|
Bairey Merz, C.N., Pepine, C.J., Walsh, M.N. and Fleg, J.L. (2017) Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade. Circulation. 135, 1075-1092. https://doi.org/10.1161/CIRCULATIONAHA.116.024534
|
[5]
|
Oxner, A., Elbaz-Greene Ahmadi, A., Argulian, E., Leipsic, J., Newby, D.E. and Narula, J. (2019) From Subclinical Atherosclerosis to Plaque Progression and Acute Coro-nary Events: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 74, 1608-1617. https://doi.org/10.1016/j.jacc.2019.08.012
|
[6]
|
Qui, F., Masih, S., Zivkovic, N., Alnasser, S., et al. (2017) Varia-tions in Use of Optimal Medical Therapy in Patients with Nonobstructive Coronary Artery Disease: A Population-Based Study. Journal of the American Heart Association, 6, e007526. https://doi.org/10.1161/JAHA.117.007526
|
[7]
|
Halcox, J., Schenke, W.H., Zalos, G., et al. (2002) Prognostic Value of Coronary Vascular Endothelial Dysfunction. Circulation, 106, 653-658. https://doi.org/10.1161/01.CIR.0000025404.78001.D8
|
[8]
|
Bugiardini, R., Manfrini, O., Pizzi, C., et al. (2004) Endothelial Function Predicts Future Development of Coronary Artery Disease: A Study of Women with Chest Pain and Normal Coronary Angiograms. Circulation, 109, 2518-2523.
https://doi.org/10.1161/01.CIR.0000128208.22378.E3
|
[9]
|
Suwaidi, J.A., Hamasaki, S., Higano, S.T., et al. (2000) Long-Term Follow-Up of Patients with Mild Coronary Artery Disease and Endothelial Dysfunction. Circulation, 101, 948-954. https://doi.org/10.1161/01.CIR.101.9.948
|
[10]
|
Von Mering, G.O., Arant, C.B., Wessel, T.R., et al. (2004) Abnormal Coronary Vasomotion as a Prognostic Indicator of Cardiovascular Events in Women: Results from the Na-tional Heart, Lung, and Blood Institute-Sponsored Women’ Ischemia Syndrome Evaluation (WISE). Circulation, 109, 722-725.
https://doi.org/10.1161/01.CIR.0000115525.92645.16
|
[11]
|
Matta, A., Bouisset, F., Lhermusier, T., Campe-lo-Parada, F., Elbaz, M., Carrié, D. and Roncalli, J. (2020) Coronary Artery Spasm: New Insights. Journal of Interven-tional Cardiology, 2020, Article ID: 5894586.
https://doi.org/10.1155/2020/5894586
|
[12]
|
Pahimi, N., Rasool, A.H.G., Sanip, Z., Bokti, N.A., Yusof, Z. and Isa, W.Y.H.W. (2022) An Evaluation of the Role of Oxidative Stress in Non-Obstructive Coronary Artery Disease. Journal of Cardiovascular Development and Disease, 9, Article 51. https://doi.org/10.3390/jcdd9020051
|
[13]
|
Wang, J.C., Normand, S.L., Mauri, L. and Kuntz, R.E. (2004) Coronary Artery Spatial Distribution of Acute Myocardial Infarction Occlusions. Circulation, 110, 278-284. https://doi.org/10.1161/01.CIR.0000135468.67850.F4
|
[14]
|
Donghee, H., Chen, B., Gransar, H., et al. (2021) Prognostic Significance of Plaque Location in Non-Obstructive Coronary Artery Disease: From the CONFIRM Registry. European Heart Journal—Cardiovascular Imaging, 23, 1240-1247.
|
[15]
|
J., Gu, Yin, Z.F., Pan, J.A., Zhang, J.F. and Wang, C.Q. (2019) Visit-to-Visit Variability in Low-Density Lipoprotein Cho-lesterol is Associated with Adverse Events in Non-Obstructive Coronary Artery Disease. The Anatolian Journal of Car-diology, 22, 117-124. https://doi.org/10.14744/AnatolJCardiol.2019.26428
|
[16]
|
Ariëns, R.A., de Lange, M., Snieder, H., Boothby, M., Spector, T.D. and Grant, P.J. (2002) Activation Markers of Coagulation and Fibrinolysis in Twins: Heritability of Theprethrombotic State. Lancet, 359, 667-671.
https://doi.org/10.1016/S0140-6736(02)07813-3
|
[17]
|
Ridker, P.M., Hennekens, C.H., Cerskus, A. and Stampfer, M.J. (1994) Plasma Concentration of Cross-Linked Fibrin Degradation Product (D-Dimer) and the Risk of Future Myo-cardial Infarction among Apparently Healthy Men. Circulation, 90, 2236-2240. https://doi.org/10.1161/01.CIR.90.5.2236
|
[18]
|
Townsend, L., Fogarty, H., Dyer, A., Martin-Loeches, I., Bannan, C., Nadarajan, P., et al. (2021) Prolonged Elevation of D-Dimer Levels in Convalescent COVID-19 Patients is Inde-pendent of the Acute Phase Response. Journal of Thrombosis and Haemostasis, 19, 1064-1070. https://doi.org/10.1111/jth.15267
|
[19]
|
Bruinstroop, E., van de Ree, M.A. and Huisman, M.V. (2009) The Use of D-Dimer in Specific Clinical Conditions: A Narrative Review. European Journal of Internal Medicine, 20, 441-446. https://doi.org/10.1016/j.ejim.2008.12.004
|
[20]
|
Hileman, C.O., Longenecker, C.T., Carman, T.L., Milne, G.L., Labbato, D.E., Storer, N.J., et al. (2012) Elevated D-Dimer Is Independently Associated with Endothelial Dysfunction: A Cross-Sectional Study in HIV-Infected Adults on Antiretroviral Therapy. Antiviral Therapy, 17, 1345-1349. https://doi.org/10.3851/IMP2297
|
[21]
|
Lin, Y., Hu, X.M., Wang, W.M., Yu, B.Y., Zhou, L.P., Zhou, Y.L., Li G. and Dong, H.J. (2022) D-Dimer Is Associated with Coronary Microvascular Dysfunction in Patients with Non-Obstructive Coronary Artery Disease and Preserved Ejection Fraction. Frontiers Cardiovascular Medicine, 9, Arti-cle ID: 937952.
|
[22]
|
Jaskanwal, D.S., Prasad, M., Zhang, M., Lennon, R.J., Herrmann, J., Lerman, L.O. and Lerman, A. (2017) High-Sensitivity C-Reactive Protein Is an Independent Marker of Abnormal Coronary Vasoreactivity in Patients with Non-Obstructive Coronary Artery Disease. American Heart Journal, 190, 1-11. https://doi.org/10.1016/j.ahj.2017.02.035
|
[23]
|
Finck, T., Hardenberg, J., Will, A., Hendrich, E., Haller, B., Marti-noff, S., Hausleiter, J. and Hadamitzky, M. (2019) 10-Year Follow-Up after Coronary Computed Tomography Angi-ography in Patients with Suspected Coronary Artery Disease. JACC: Cardiovascular Imaging, 12, 1330-1338.
https://doi.org/10.1016/j.jcmg.2018.07.020
|